hydralazine has been researched along with procainamide in 118 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 76 (64.41) | 18.7374 |
1990's | 16 (13.56) | 18.2507 |
2000's | 18 (15.25) | 29.6817 |
2010's | 7 (5.93) | 24.3611 |
2020's | 1 (0.85) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Drayer, DE; Reidenberg, MM | 1 |
Jones, WN; Trinca, CE; Walson, PD | 1 |
Gladkikh, SP; Piruzian, LA; Podymov, VK | 2 |
Freeman, RW; Harbison, RD; Oates, JA; Woosley, RL | 1 |
CHase, PH; Lee, SL | 1 |
Carel, RS; Cordoba, O; Gutman, A; Shapiro, MS; Taragan, R | 1 |
Fenster, PE; Pinnas, JL | 1 |
Bach, JF; Dandavino, R | 1 |
Schwarz, JA | 1 |
Hayes, AH; Schneck, DW; Shiroff, RA; Sprouse, JS | 1 |
DeWitt, FO; Hayes, AH; Miller, K; Schneck, DW; Sprouse, JS; Vary, JE | 1 |
Maas, D; Schubothe, H | 1 |
Cohmen, G | 1 |
Katsutani, N; Shionoya, H | 1 |
Rubin, RL | 1 |
Koopman, WJ; Zacharias, W | 1 |
Fritzler, MJ; Gohill, J; Pauls, JD | 1 |
Sim, E | 2 |
Burlingame, RW; Rubin, RL | 1 |
Andersson, M; Dahlbäck, B; Englund, G; Hanson, A | 1 |
Arndt, RE; Kotzin, BL; Portanova, JP; Tan, EM | 1 |
Bernstein, RM; Craft, JE; Hardin, JA; Harding, MW; Radding, JA | 1 |
Cornacchia, E; Golbus, J; Hanash, S; Maybaum, J; Richardson, B; Strahler, J | 2 |
Biarese, V; Cargnino, M; Lerda, R; Lovisetto, P; Mairano, D; Marchi, L | 1 |
Clark, DW | 1 |
Kucharz, EJ | 1 |
Honda, M; Nagoshi, H; Naito, M; Nishikai, M; Sato, A; Sugimoto, M | 1 |
Boucek, RJ; Colburn, KK; Heng, MK; Weisbart, RH; Whang, SH; Yee, WS | 1 |
Stevens, MB | 1 |
Messner, RP; Thomas, TJ | 1 |
Chan, EK; Pollard, KM; Rubin, RL; Tan, EM; Tang, FL; Tsay, G | 1 |
Rubin, RL; Totoritis, MC | 1 |
Barland, P; Epstein, A | 1 |
de Boccardo, G; Drayer, D; Novogrodsky, A; Reidenberg, MM; Rubin, AL; Stenzel, KH | 1 |
Kale, SA | 1 |
Cush, JJ; Goldings, EA | 1 |
Rasmussen, K | 1 |
de Sèze, S; Dorfmann, H; Kahn, MF | 2 |
Estes, D; Peltier, AP | 1 |
Asboe-Hansen, G; Blumenkrantz, N | 1 |
Tan, EM | 1 |
Halberg, P; Kobayasi, T; Ullman, S; Wiik, A | 1 |
Harpey, JP | 1 |
McEwen, J | 1 |
Almeyda, J; Levantine, A | 1 |
Losada, M; Meruane, J | 1 |
Eldredge, NT; Jiller, JJ; van Robertson, WB | 1 |
Hart, FD | 1 |
Feltkamp, TE; ten Veen, JH | 1 |
ten Veen, JH | 1 |
Blomgren, SE | 1 |
Galea, G; Geavlete, A | 1 |
Alarcón-Segovia, D | 1 |
Catania, PN; King, JC | 1 |
Lee, SL; Peress, NS; Siegel, M | 1 |
Clark, BG; Vestal, RE | 1 |
Skakun, NP | 1 |
DeSwarte, RD | 1 |
Reidenberg, MM | 1 |
Jacobs, RP | 1 |
Blackshear, PJ; Kahn, CR; Kriauciunas, KA; Rotner, HE | 1 |
Wollina, U | 1 |
Harmon, CE; Portanova, JP | 1 |
Holborow, EJ | 1 |
Balazs, T; Robinson, CJ | 1 |
Agnello, VD; Joslin, FG; Portanova, JP; Rubin, RL; Tan, EM | 1 |
Weinstein, A | 1 |
Schoen, RT; Trentham, DE | 1 |
Portanova, JP; Tan, EM | 1 |
Hess, EV | 2 |
Parker, CW | 1 |
Greenblatt, DJ; Lloyd, BL | 1 |
Kotler, MN; Segal, BL | 1 |
Alloway, JA; Salata, MP | 1 |
Edworthy, SM; Fritzler, MJ; Pauls, JD | 1 |
Ayer, LM; Edworthy, SM; Fritzler, MJ | 1 |
Jiang, X; Khursigara, G; Rubin, RL | 1 |
Cohen, MG | 1 |
Park, BK; Tingle, MD | 1 |
Miyasaka, N | 1 |
Ishizaki, T; Ohnishi, A | 1 |
Chang, S; Hemati, N; Johnson, K; Richardson, B; Yung, R | 1 |
Amano, K; Takeuchi, T | 1 |
Attwood, J; Deng, C; Lu, Q; Rao, T; Richardson, B; Yung, R; Zhang, Z | 1 |
Acuña, C; Chavez, A; Dueñas-Gonzalez, A; Lizano, M; Mariscal, I; Perez-Cardenas, E; Salazar, AM; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C | 1 |
Dzierzewicz, Z; Gwoździński, K; Jóźwiak, Z; Koceva-Chyła, A; Weglarz, L | 1 |
Richardson, B | 1 |
Lu, Q; Richardson, BC; Wu, A | 1 |
Suwa, A | 1 |
Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
Nonaka, Y; Takei, S | 1 |
Lu, Q; Zhou, Y | 1 |
Del Giglio, M; Girolomoni, G; Schena, D; Vedove, CD | 1 |
Crosti, C; Marzano, AV; Vezzoli, P | 1 |
Katz, U; Zandman-Goddard, G | 1 |
Chen, SJ; Hii, HP; Ka, SM; Liao, MH; Shih, CC; Tsao, CM; Wu, CC | 1 |
Carmona-Rivera, C; Grayson, PC; Irizarry-Caro, JA; Kaplan, MJ; Khaznadar, SS; Schwartz, DM | 1 |
He, Y; Sawalha, AH | 1 |
Arnaud, L; Chasset, F; Gavand, PE; Lambert, A; Lebrun-Vignes, B; Martin, T; Mertz, P; Muller, C; Salem, JE; Sibilia, J; Tebacher-Alt, M | 1 |
Guo, L; Guo, Y; Liao, S; Liu, HF; Pan, Q; Wang, S; Zhao, C | 1 |
34 review(s) available for hydralazine and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced systemic lupus erythematosus: a critical review.
Topics: Adult; Allopurinol; Anti-Arrhythmia Agents; Anticonvulsants; Antithyroid Agents; Antitubercular Agents; Contraceptives, Oral, Synthetic; Female; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; Male; Middle Aged; Penicillamine; Procainamide; Psychotropic Drugs; Reserpine; Sulfonamides; Tuberculosis | 1975 |
Drug-induced immune complex disease.
Topics: Amino Acid Sequence; Antigen-Antibody Complex; Complement Activation; Complement C4; Humans; Hydralazine; Immune Complex Diseases; Lupus Erythematosus, Systemic; Molecular Sequence Data; Penicillamine; Procainamide | 1991 |
Drug-induced immune-complex disease.
Topics: Humans; Hydralazine; Immune Complex Diseases; Isoniazid; Lupus Erythematosus, Systemic; Penicillamine; Practolol; Procainamide | 1989 |
[Drug-induced lupus].
Topics: Acetylation; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Anticonvulsants; B-Lymphocytes; Diagnosis, Differential; HLA Antigens; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Lymphocyte Activation; Penicillamine; Procainamide; Sulfasalazine; T-Lymphocytes, Regulatory | 1985 |
Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Topics: Acetylation; Anticonvulsants; Antidepressive Agents, Tricyclic; Debrisoquin; Disease; Drug Interactions; Genetic Variation; Humans; Hydralazine; Isoniazid; Oxidation-Reduction; Pharmaceutical Preparations; Phenelzine; Phenotype; Procainamide; Racial Groups; Sparteine; Sulfasalazine | 1985 |
[Pathogenesis of drug-induced collagenosis-like syndrome].
Topics: Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1987 |
Connective tissue disease in the elderly.
Topics: Aged; Connective Tissue Diseases; Dermatomyositis; Female; Giant Cell Arteritis; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Myositis; Polymyalgia Rheumatica; Procainamide; Scleroderma, Systemic; Sjogren's Syndrome; Vasculitis | 1986 |
Drug-induced systemic lupus erythematosus. Differentiating it from the real thing.
Topics: Diagnosis, Differential; Female; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Male; Procainamide; Risk | 1985 |
Drug-induced lupus: clinical spectrum and pathogenesis.
Topics: Acetylation; Adult; Aged; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Black People; Brain; Chlorpromazine; Female; Heart; Humans; Hydralazine; Isoniazid; Kidney; Liver; Lung; Lupus Erythematosus, Systemic; Male; Methyldopa; Muscles; Phenotype; Procainamide | 1985 |
Systemic lupus erythematosus.
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Female; Hepatitis; Humans; Hydralazine; Immunoglobulins; Kidney; Lupus Erythematosus, Systemic; Male; Nephritis; Neutrophils; Prednisone; Procainamide; Prognosis; Skin | 1973 |
[Iatrogenic lupus: present status of the problem. II. Physiopathology of induced lupus].
Topics: Animals; Antibodies, Antinuclear; Disease Models, Animal; DNA, Viral; Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NZB; Neutrophils; Nucleic Acid Denaturation; Procainamide | 1972 |
Antinuclear antibodies.
Topics: Animals; Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Autoantigens; Cytotoxicity Tests, Immunologic; DNA; Fluorescent Antibody Technique; Humans; Hydralazine; Immune Adherence Reaction; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Nephritis; Neutrophils; Nucleoproteins; Procainamide; Sjogren's Syndrome | 1972 |
Lupus-like syndromes induced by drugs.
Topics: Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Chlorpromazine; DNA, Single-Stranded; Drug-Related Side Effects and Adverse Reactions; False Positive Reactions; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Hydralazine; Isoantigens; Isoniazid; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; Neutrophils; Nucleoproteins; Penicillamine; Phenytoin; Procainamide; Remission, Spontaneous; Syphilis Serodiagnosis | 1974 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; Drug Eruptions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Mercury; Methyldopa; Nitroglycerin; Pentaerythritol Tetranitrate; Procainamide; Quinidine; Thiazines | 1973 |
[Generalized lupus erythematosus caused by methyl-phenyl-ethyl-hydantoin].
Topics: Adult; Autoimmune Diseases; Female; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Mephenytoin; Procainamide | 1967 |
Drug-induced lupus syndromes.
Topics: Antibodies, Antinuclear; Anticonvulsants; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Procainamide | 1969 |
[Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
Topics: Acetylation; Acetyltransferases; Dapsone; Humans; Hydralazine; Inactivation, Metabolic; Isoniazid; Kinetics; Liver; Pharmaceutical Preparations; Phenotype; Procainamide; Sulfamethazine; Sulfasalazine | 1982 |
Drug-induced lupus: clinical and serological studies.
Topics: Acetyltransferases; Adult; Antibodies, Antinuclear; Anticonvulsants; Arthritis; Chlorpromazine; Cross Reactions; Female; Genes, MHC Class II; HLA-DR Antigens; Humans; Hydralazine; Hypertension; Isoniazid; Joint Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Pain; Pleural Effusion; Pleurisy; Procainamide; T-Lymphocytes | 1982 |
Drug-induced systemic lupus erythematosus.
Topics: Antibodies, Antinuclear; Anticonvulsants; Chlorpromazine; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Procainamide | 1980 |
Drug-induced lupus: an adjuvant disease?
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1981 |
Quinidine-induced rheumatic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Atrial Fibrillation; Child; Diagnosis, Differential; Female; Hematologic Tests; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Middle Aged; Polymyalgia Rheumatica; Procainamide; Prognosis; Quinidine | 1995 |
Drug-induced lupus.
Topics: Antibodies, Antinuclear; Anticonvulsants; Ethosuximide; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Procainamide; Syndrome | 1996 |
[Drug-induced pericarditis].
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Humans; Hydralazine; Pericarditis; Procainamide | 1996 |
[Drug-induced lupus erythematosus].
Topics: Autoimmunity; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; Prognosis | 2000 |
DNA methylation and autoimmune disease.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Azacitidine; Cell Communication; DNA Methylation; Humans; Hydralazine; In Vitro Techniques; Lupus Erythematosus, Systemic; Models, Immunological; Procainamide; T-Lymphocytes | 2003 |
[Immunologic tests: Anti-histone antibodies].
Topics: Antibodies, Antinuclear; Biomarkers; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Histones; Humans; Hydralazine; Immunoblotting; Lupus Erythematosus, Systemic; Lupus Vulgaris; Procainamide | 2005 |
[Drug-induced lupus erythematosus].
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; Time Factors | 2007 |
DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
Topics: Autoantibodies; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cytokines; Cytotoxicity, Immunologic; DNA Methylation; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; T-Lymphocyte Subsets | 2008 |
Drug-induced lupus erythematosus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Antibodies; Antifungal Agents; Antihypertensive Agents; Antitubercular Agents; Arthritis; Calcium Channel Blockers; Exanthema; Humans; Hydralazine; Interferons; Isoniazid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Naphthalenes; Procainamide; Serositis; Sodium Chloride Symporter Inhibitors; Terbinafine; Tumor Necrosis Factor-alpha | 2009 |
Drug-induced lupus: an update on its dermatologic aspects.
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antihypertensive Agents; Antitubercular Agents; Autoantibodies; Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Minocycline; Procainamide; Skin Diseases | 2009 |
Drug-induced lupus: an update.
Topics: Anti-Arrhythmia Agents; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; Tumor Necrosis Factor-alpha | 2010 |
Drug-induced lupus erythematosus: an update on drugs and mechanisms.
Topics: Autoimmunity; Genetic Predisposition to Disease; Humans; Hydralazine; Immunologic Factors; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Procainamide; Tumor Necrosis Factor-alpha | 2018 |
Mechanistic Insights of Chemicals and Drugs as Risk Factors for Systemic Lupus Erythematosus.
Topics: Autoimmune Diseases; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; Risk Factors | 2020 |
84 other study(ies) available for hydralazine and procainamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Clinical consequences of polymorphic acetylation of basic drugs.
Topics: Acetylation; Antibodies, Antinuclear; Biotransformation; Chemical and Drug Induced Liver Injury; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Pharmaceutical Preparations; Phenelzine; Phenotype; Polymorphism, Genetic; Procainamide; Sulfasalazine | 1977 |
Drug-induced systemic lupus erythematosus.
Topics: Anticonvulsants; Antihypertensive Agents; Antipsychotic Agents; Antitubercular Agents; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Procainamide | 1978 |
[Molecular aspects of disorders in fibrillogenesis of connective tissue caused by medicinal ligands].
Topics: Animals; Connective Tissue; Humans; Hydralazine; Isoniazid; Penicillamine; Phenytoin; Procainamide; Protein-Lysine 6-Oxidase | 1979 |
[Molecular aspects of connective tissue fibrillogenesis disorders caused by drug ligands].
Topics: Animals; Chemical Phenomena; Chemistry; Collagen; Collagen Diseases; Elastin; Humans; Hydralazine; Isoniazid; Ligands; Penicillamine; Phenytoin; Procainamide; Protein-Lysine 6-Oxidase | 1979 |
Evidence for the biotransformation of procainamide to a reactive metabolite.
Topics: Acetylation; Animals; Biotransformation; Hydralazine; Male; Mice; Microsomes, Liver; NADP; Phenobarbital; Proadifen; Procainamide; Salmonella typhimurium | 1979 |
LE cells in pleural fluid.
Topics: Aged; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Neutrophils; Pleural Effusion; Procainamide | 1979 |
ANA, DNA, and SLE.
Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; DNA; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1977 |
[Disseminated lupus erythematosus: etiopathogenic factors].
Topics: Animals; Antibodies; Autoantibodies; B-Lymphocytes; Female; Humans; Hydantoins; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred NZB; Mice, Inbred Strains; Procainamide; Sunlight; T-Lymphocytes; Virus Diseases | 1977 |
[Drug-induced disorders of lupus erythematosus type (author's transl)].
Topics: Animals; Antibody Formation; Anticonvulsants; Chlorpromazine; Drug-Related Side Effects and Adverse Reactions; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Penicillamine; Procainamide; Rats | 1977 |
The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase.
Topics: Acetylation; Acetyltransferases; Animals; Hydralazine; In Vitro Techniques; Kinetics; Liver; Male; Procainamide; Rats | 1978 |
Plasma levels of free and acid-labile hydralazine: effects of multiple dosing and of procainamide.
Topics: Acetylation; Adult; Drug Interactions; Female; Humans; Hydralazine; Male; Phenotype; Procainamide; Time Factors | 1978 |
[Drug-induced systemic lupus erythematosus (author's transl)].
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antibody Formation; Autoantibodies; Child; Chlorpromazine; Female; Humans; Hydralazine; Immune Tolerance; Lupus Erythematosus, Systemic; Methyldopa; Practolol; Procainamide | 1977 |
[Drug-induced lupus erythematosus-like syndromes].
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydantoins; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Lymphocytes; Male; Middle Aged; Procainamide | 1976 |
Drug-specific immune responses induced by procainamide, hydralazine and isoniazid in guinea-pigs.
Topics: Animals; Antibodies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Hydralazine; Isoniazid; Ovalbumin; Penicillins; Procainamide; Serum Albumin, Bovine | 1992 |
Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs.
Topics: Antibody Specificity; Autoantibodies; Chromatin; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Neutrophils; Procainamide; Quinidine | 1992 |
Lupus-inducing drugs alter the structure of supercoiled circular DNA domains.
Topics: Acecainide; Animals; Antibodies; Canavanine; DNA, Superhelical; Electrophoresis, Agar Gel; Escherichia coli; Hydralazine; Lupus Erythematosus, Systemic; Plasmids; Procainamide | 1990 |
Antibodies from patients with systemic lupus erythematosus and drug-induced lupus bind determinants on histone 5 (H5).
Topics: Amino Acid Sequence; Animals; Autoantibodies; Chickens; Cross Reactions; Epitopes; Histones; Humans; Hydralazine; Immunoblotting; Lupus Erythematosus, Systemic; Molecular Sequence Data; Peptides; Procainamide | 1990 |
Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.
Topics: Autoantibodies; Chlorpromazine; Chromatin; DNA; Enzyme-Linked Immunosorbent Assay; Histones; Humans; Hydralazine; Immunoglobulin G; Immunoglobulin M; Lupus Vulgaris; Procainamide; Quinidine | 1991 |
Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
Topics: Antihypertensive Agents; Complement C3; Complement C4; Dihydralazine; Humans; Hydralazine; Hydroxylamine; Hydroxylamines; Procainamide; Pyridazines; Vasodilator Agents | 1991 |
Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Autoantibodies; Epitopes; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Macromolecular Substances; Mice; Peptide Fragments; Procainamide | 1987 |
Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus.
Topics: Autoantigens; Epitopes; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1987 |
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
Topics: Acecainide; Autoantibodies; Autoimmune Diseases; Chromatography, High Pressure Liquid; DNA; Humans; Hydralazine; In Vitro Techniques; Methylation; Phthalazines; Procainamide; T-Lymphocytes | 1988 |
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Topics: Autoimmune Diseases; DNA (Cytosine-5-)-Methyltransferases; Humans; Hydralazine; Immunosuppressive Agents; Lupus Vulgaris; Lymphocyte Activation; Procainamide; T-Lymphocytes | 1988 |
[Procainamide- and hydralazine-induced antinuclear antibodies in Japanese].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Asian People; Female; Humans; Hydralazine; Japan; Lupus Erythematosus, Systemic; Male; Middle Aged; Procainamide | 1987 |
Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
Topics: Adult; Aged; Antibodies, Antinuclear; DNA, Single-Stranded; Female; Fluorescent Antibody Technique; Guanosine; Histones; Humans; Hydralazine; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Nucleosides; Procainamide | 1986 |
Effects of lupus-inducing drugs on the B to Z transition of synthetic DNA.
Topics: Canavanine; Circular Dichroism; DNA; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Nucleic Acid Conformation; Penicillamine; Polydeoxyribonucleotides; Procainamide | 1986 |
IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.
Topics: Antibodies, Monoclonal; Autoantibodies; Autoimmune Diseases; DNA; Enzyme-Linked Immunosorbent Assay; Histones; Humans; Hydralazine; Immunoglobulin G; Lupus Erythematosus, Systemic; Procainamide; Quinidine; Sjogren's Syndrome | 1986 |
Drug-induced lupus. Genetic, clinical, and laboratory features.
Topics: Aged; Antibodies, Antinuclear; Diagnosis, Differential; Humans; Hydralazine; Immunoglobulins; Lupus Erythematosus, Systemic; Procainamide; Risk; Time Factors | 1985 |
The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Child; Disopyramide; Female; Fluorescent Antibody Technique; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Middle Aged; Penicillamine; Phenytoin; Procainamide | 1985 |
Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups.
Topics: Adult; B-Lymphocytes; Cadaverine; Cell Differentiation; Depression, Chemical; Diamines; Hemolytic Plaque Technique; Humans; Hydralazine; Immunoglobulin G; Immunosuppressive Agents; Lymphocyte Activation; Lymphokines; Middle Aged; Pokeweed Mitogens; Procainamide | 1985 |
[Drug-induced lupus erythematosus disseminatus].
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticonvulsants; Antihypertensive Agents; Antithyroid Agents; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1972 |
Connective-tissue effects of drugs causing lupoid syndrome.
Topics: Animals; Carbon Radioisotopes; Chick Embryo; Chlorpromazine; Collagen; Depression, Chemical; Glucosamine; Hydralazine; Hydroxylation; Hydroxylysine; Hydroxyproline; Lupus Erythematosus, Systemic; Lysine; Mucoproteins; Procainamide; Proline; Tibia | 1974 |
Drug-induced autoimmune disease.
Topics: Acetyltransferases; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Binding Sites; DNA; Epitopes; Humans; Hydralazine; Immunodiffusion; Lupus Erythematosus, Systemic; Nucleic Acid Conformation; Nucleoproteins; Procainamide; Protein Binding | 1974 |
Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
Topics: Adult; Animals; Antibodies, Antinuclear; Biopsy; Complement Fixation Tests; Female; Fluorescent Antibody Technique; Humans; Hydralazine; Immune Sera; Immunoglobulin G; Immunoglobulin M; Leukocytes; Lupus Erythematosus, Systemic; Male; Microscopy, Electron; Microscopy, Fluorescence; Middle Aged; Procainamide; Rabbits; Skin | 1974 |
Letter: Aetiology of systemic lupus erythematosus.
Topics: Acetylation; Antibody Formation; DNA; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Procainamide | 1974 |
The interaction of lupus-inducing drugs with deoxyribonucleic acid.
Topics: Adult; Animals; Cattle; Child; DNA; DNA, Single-Stranded; Hot Temperature; Humans; Hydralazine; Immunodiffusion; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Nucleic Acid Conformation; Nucleic Acid Denaturation; Optical Rotation; Oxazoles; Phenytoin; Procainamide; Propylthiouracil; Thymus Gland; Trimethadione; Viscosity | 1974 |
Drug-induced arthritis.
Topics: Acute Disease; Anticoagulants; Antihypertensive Agents; Arteritis; Arthritis; Barbiturates; Contraceptives, Oral; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Edema; Gout; Humans; Hydralazine; Iatrogenic Disease; Lupus Erythematosus, Systemic; Mersalyl; Osteomalacia; Osteoporosis; Penicillins; Procainamide; Pyrazinamide; Succinylcholine; Sulfonamides; Water-Electrolyte Balance | 1974 |
[Iatrogenic lupus: current status of the question. I. Clinical study and main drugs responsible].
Topics: Antibodies, Antinuclear; Contraceptives, Oral; Diagnosis, Differential; Humans; Hydralazine; Iatrogenic Disease; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Procainamide; Sulfonamides | 1972 |
Medical grand rounds--from the Medical College of Virginia. Drug-induced lupus erythematosus.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Disease Susceptibility; DNA; DNA, Single-Stranded; Female; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Procainamide; Tuberculosis, Pulmonary | 1974 |
Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Antibody Formation; Chlorthalidone; Coombs Test; DNA; Female; Fluorescent Antibody Technique; Genetics; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Male; Methyldopa; Mice; Mice, Inbred Strains; Procainamide; Sex Factors | 1972 |
Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.
Topics: Animals; Antibody Formation; Autoantibodies; Cell Membrane; Chlorthalidone; Fluorescent Antibody Technique; Hydralazine; Isoniazid; Liver; Lupus Erythematosus, Systemic; Lymphocytes; Methyldopa; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Smooth; Muscles; Procainamide | 1973 |
Drug-induced lupus erythematosus.
Topics: Antibodies; Cell Membrane; DNA; Drug Hypersensitivity; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Prednisone; Procainamide | 1973 |
[Medicaments as iatrogenic factors in the onset of lupoid syndromes].
Topics: Adolescent; Adult; Anticonvulsants; Humans; Hydralazine; Iatrogenic Disease; Isoniazid; Lupus Erythematosus, Systemic; Middle Aged; Phenytoin; Procainamide | 1974 |
Drug-induced lupus syndrome.
Topics: Acetylation; Anticonvulsants; Female; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Male; Procainamide | 1974 |
The physico-chemical incompatibilities of selected cardiovascular and psychotherapeutic agents with sodium ethacrynate.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Chlorpromazine; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Ethacrynic Acid; Hydralazine; Hydrogen-Ion Concentration; Procainamide; Prochlorperazine; Promazine; Reserpine; Spectrum Analysis; Time Factors; Tolazoline; Tranquilizing Agents; Triflupromazine; Ultraviolet Rays | 1972 |
Drug-induced lupus syndromes.
Topics: Anticonvulsants; Drug Hypersensitivity; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Procainamide | 1970 |
Drug-induced systemic lupus erythematosus.
Topics: Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1969 |
The epidemiology of drug-induced systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Child; Epilepsy; Female; Heart Diseases; Humans; Hydralazine; Hypertension; Isoniazid; Lupus Erythematosus, Systemic; Male; Middle Aged; New York City; Phenytoin; Procainamide | 1967 |
Adverse drug reactions in the elderly: case studies.
Topics: Acetazolamide; Aged; Anemia, Hemolytic; Bromocriptine; Captopril; Chlorpropamide; Cimetidine; Clonidine; Dienestrol; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydralazine; Lung Diseases; Male; Middle Aged; Nitrofurantoin; Pancreatitis; Papaverine; Peripheral Nervous System Diseases; Procainamide; Propranolol; Sulindac; Theophylline; Timolol | 1984 |
Drug allergy--problems and strategies.
Topics: Anaphylaxis; Anemia, Hemolytic; Antigen-Antibody Complex; Desensitization, Immunologic; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Encephalomyelitis, Acute Disseminated; Exanthema; Humans; Hydralazine; Immunity, Cellular; Isoniazid; Kidney Diseases; Liver Diseases; Lupus Erythematosus, Systemic; Lymphoid Tissue; Methyldopa; Nephritis, Interstitial; Penicillins; Phenytoin; Procainamide; Respiratory Hypersensitivity; Vasculitis, Leukocytoclastic, Cutaneous | 1984 |
The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
Topics: Acecainide; Acetylation; Adult; Female; Humans; Hydralazine; Hydrazines; Isoniazid; Lupus Erythematosus, Systemic; Lupus Vulgaris; Lymphocytes; Phenotype; Procainamide; Time Factors | 1981 |
Drug-induced rheumatic diseases.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antineoplastic Agents; Diuretics; Gout; Heparin; Humans; Hydralazine; Lupus Erythematosus, Systemic; Myositis; Osteomalacia; Osteonecrosis; Osteoporosis; Procainamide; Rheumatic Diseases; Scleroderma, Systemic; Thyroid Hormones; Uric Acid | 1984 |
Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Female; Glucose Tolerance Test; Humans; Hydralazine; Hypoglycemia; Insulin; Lupus Erythematosus, Systemic; Procainamide | 1983 |
[Drug-induced lupus erythematosus syndrome. Pathogenesis and relation to systemic lupus erythematosus].
Topics: Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Lupus Erythematosus, Systemic; Phenylbutazone; Phenytoin; Procainamide; Syndrome | 1984 |
Drug effects on autoantibodies and immune complexes.
Topics: Acetylation; Antibodies, Antinuclear; Antigen-Antibody Complex; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Binding Sites; Complement C1; Humans; Hydralazine; Immunoglobulin M; Lupus Erythematosus, Systemic; Methyldopa; Penicillamine; Procainamide; Rheumatoid Factor | 1980 |
Drug-induced antinuclear antibodies in the guinea pig.
Topics: Acetanilides; Animals; Antibodies, Antinuclear; Antibody Formation; Caffeine; Guinea Pigs; Hydralazine; Male; Procainamide | 1982 |
Reactivity of anti-histone antibodies induced by procainamide and hydralazine.
Topics: Adult; Aged; Animals; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; Connective Tissue Diseases; Female; Histones; Humans; Hydralazine; Immunoglobulin G; Immunoglobulin M; Joint Diseases; Male; Mice; Middle Aged; Procainamide | 1982 |
The role of histones as nuclear autoantigens in drug-related lupus erythematosus.
Topics: Animals; Antibodies, Antinuclear; Antibody Formation; Antibody Specificity; Antigens; Autoantigens; Cell Nucleus; Chromosomal Proteins, Non-Histone; Fluorescent Antibody Technique; Histones; Humans; Hydralazine; Kidney; Lupus Erythematosus, Systemic; Mice; Procainamide | 1981 |
Drug-related lupus.
Topics: Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide | 1982 |
Introduction to drug-related lupus.
Topics: Acetylation; Acetyltransferases; Animals; Anticonvulsants; Autoimmune Diseases; Child; Chlorpromazine; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Phenothiazines; Procainamide; Sulfadiazine | 1981 |
Hapten immunology and allergic reactions in humans.
Topics: Animals; Autoimmune Diseases; Carrier Proteins; Drug Hypersensitivity; Environmental Health; Haptens; HLA Antigens; Humans; Hydralazine; Immunization, Passive; Isoniazid; Lupus Erythematosus, Systemic; Macromolecular Substances; Methyldopa; Nitrobenzenes; Nucleic Acids; Penicillins; Procainamide | 1981 |
Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Brain; Drug Interactions; Guanethidine; Humans; Hydralazine; Hypertension; Lidocaine; Methyldopa; Procainamide; Psychotropic Drugs; Quinidine; Seizures | 1981 |
The inflamed heart: pericarditis in the elderly.
Topics: Aged; Cardiac Tamponade; Daunorubicin; Echocardiography; Heart Neoplasms; Humans; Hydralazine; Myocardial Infarction; Pericarditis; Pericarditis, Constrictive; Postpericardiotomy Syndrome; Procainamide; Syndrome; Uremia | 1980 |
Epitope mapping of histone 5 (H5) with systemic lupus erythematosus, procainamide-induced lupus and hydralazine-induced lupus sera.
Topics: Amino Acid Sequence; Antibody Specificity; Autoantibodies; Blotting, Western; Epitopes; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Molecular Sequence Data; Procainamide; Protein Conformation | 1993 |
Effect of procainamide and hydralazine on poly (ADP-ribosylation) in cell lines.
Topics: Acecainide; Cell Line, Transformed; Humans; Hydralazine; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Procainamide; Tumor Cells, Cultured | 1993 |
Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.
Topics: Animals; Biological Assay; Biotransformation; Cell Death; Chlorpromazine; Humans; Hydralazine; Hydrogen Peroxide; Isoniazid; Lupus Erythematosus, Systemic; Mice; Neutrophil Activation; Neutrophils; Peroxidase; Procainamide; Propylthiouracil; Quinidine; Tumor Cells, Cultured | 1994 |
Antibodies to dsDNA in drug induced lupus erythematosus.
Topics: Antibodies, Antinuclear; Artifacts; DNA; Humans; Hydralazine; Lupus Erythematosus, Systemic; Nucleic Acid Denaturation; Procainamide; Timolol | 1994 |
The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
Topics: Animals; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythrocyte Count; Hematologic Diseases; Humans; Hydralazine; In Vitro Techniques; Liver; Male; Methemoglobin; Microsomes, Liver; Models, Biological; Neutrophils; Pharmaceutical Preparations; Primaquine; Procainamide; Rats; Rats, Wistar | 1993 |
Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo.
Topics: Animals; Antibody Formation; Autoantibodies; Autoimmunity; DNA Methylation; Female; Gene Expression; Hydralazine; Hydroxyurea; Lupus Vulgaris; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Male; Mice; Mice, Inbred AKR; Mice, Inbred NZB; Procainamide; T-Lymphocytes | 1997 |
Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.
Topics: Animals; Autoimmunity; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Activation; Female; Humans; Hydralazine; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Lupus Erythematosus, Systemic; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Procainamide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; T-Lymphocytes | 2003 |
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Head and Neck Neoplasms; Humans; Hydralazine; Mice; Mice, Nude; Procainamide; Receptors, Estrogen; Receptors, Retinoic Acid; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Evaluation of hydralazine and procainamide effects on fibroblast membrane fluidity.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Cell Membrane; Cells, Cultured; Cricetinae; Electron Spin Resonance Spectroscopy; Fibroblasts; Hydralazine; Membrane Fluidity; Mice; NIH 3T3 Cells; Procainamide; Spectrometry, Fluorescence | 2003 |
Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs.
Topics: 5' Flanking Region; Adult; Antigens, CD; Base Sequence; CD27 Ligand; Cells, Cultured; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation; Humans; Hydralazine; Jurkat Cells; Lupus Erythematosus, Systemic; Membrane Proteins; Middle Aged; Molecular Sequence Data; Procainamide; Promoter Regions, Genetic; RNA, Messenger; T-Lymphocyte Subsets | 2005 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats.
Topics: Acidosis; Animals; Bicarbonates; Biomarkers; Creatinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; Drug Evaluation, Preclinical; Electrolytes; Endotoxemia; Endotoxins; Hydralazine; Hypertension; Interleukin-6; Kidney; Lung; Male; Muscle, Skeletal; Neutrophils; Procainamide; Random Allocation; Rats; Rats, Wistar; Rhabdomyolysis; Superoxides; Tachycardia | 2016 |
Brief Report: Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation.
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antihypertensive Agents; Antipsychotic Agents; Autoimmunity; Clozapine; Extracellular Traps; Flow Cytometry; Humans; Hydralazine; Microscopy, Fluorescence; Minocycline; Neutrophils; Procainamide; Proteomics; Signal Transduction | 2018 |
Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.
Topics: Adalimumab; Adult; Antirheumatic Agents; Databases, Factual; Etanercept; Female; Humans; Hydralazine; Infliximab; Lupus Erythematosus, Systemic; Male; Middle Aged; Pharmacovigilance; Procainamide; Retrospective Studies; World Health Organization | 2019 |